J N Bruun
Overview
Explore the profile of J N Bruun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
836
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jensenius M, Winje B, Blomberg B, Mengshoel A, Lippe B, Hannula R, et al.
Int J Tuberc Lung Dis
. 2016 May;
20(6):786-92.
PMID: 27155182
Setting: The management of multidrug-resistant tuberculosis (MDR-TB) is strictly regulated in Norway. However, nationwide studies of the epidemic are lacking. Objective: To describe the MDR-TB epidemic in Norway over two...
2.
Pullar N, Steinum H, Tonby K, Heggelund L, Leiva R, Ofstad R, et al.
Int J Tuberc Lung Dis
. 2014 Jan;
18(2):180-7.
PMID: 24429310
Objective: To determine the prevalence and predictors of positive interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs) in human immunodeficiency virus (HIV) infected patients in Norway, a low tuberculosis...
3.
Kivuyo S, Johannessen A, Troseid M, Kasubi M, Gundersen S, Naman E, et al.
Int J STD AIDS
. 2011 Dec;
22(12):719-21.
PMID: 22174052
The difficulty of diagnosing HIV in infants is a major obstacle to early antiretroviral therapy (ART) in resource-limited settings. As serological tests are unreliable during the first 18 months of...
4.
Maagaard A, Holberg-Petersen M, Kvittingen E, Sandvik L, Bruun J
HIV Med
. 2005 Nov;
7(1):53-8.
PMID: 16313293
Objectives: Mitochondrial toxicity is believed to be the main reason for adverse effects related to nucleoside reverse transcriptase inhibitors (NRTIs). The aim of the present study was to compare mitochondrial...
5.
Bergersen B, Sandvik L, Ellingsen I, Bruun J
HIV Med
. 2005 Jul;
6(4):260-7.
PMID: 16011531
Objectives: To identify clinical factors associated with HIV-associated lipoatrophy and to evaluate body composition changes, blood pressure and lipid levels in lipoatrophic subjects 3-4 years after the atrophy diagnosis. Methods:...
6.
Ormaasen V, Sandvik L, Asjo B, Holberg-Petersen M, Gaarder P, Bruun J
HIV Med
. 2004 Nov;
5(6):400-6.
PMID: 15544691
Objectives: The aim of this study was to evaluate the association between genotypic drug resistance and the occurrence of HIV-related diseases and death in HIV-1-infected adults on antiretroviral therapy. Methods:...
7.
Bergersen B, Sandvik L, Bruun J, Tonstad S
Eur J Clin Microbiol Infect Dis
. 2004 Aug;
23(8):625-30.
PMID: 15322938
Highly active antiretroviral therapy (HAART) may induce dyslipidemia and thus increase the risk of future cardiovascular heart disease (CHD). In this cross-sectional study performed in 2000-2001, the prevalence of a...
8.
Bergersen B, Sandvik L, Dunlop O, Birkeland K, Bruun J
Eur J Clin Microbiol Infect Dis
. 2003 Nov;
22(12):731-6.
PMID: 14610658
Highly active antiretroviral therapy (HAART) may induce dyslipidemia, insulin resistance and body fat distribution similar to that seen in the metabolic syndrome. Hypertension is often a part of the classic...
9.
Leegaard T, Caugant D, Froholm L, Hoiby E, Ronning E, Sandven P, et al.
Eur J Clin Microbiol Infect Dis
. 2003 Jan;
21(12):856-63.
PMID: 12525920
The aim of the present study was to investigate whether HIV-infected patients, a group that is supposedly at risk for infection with antibiotic-resistant microbes, really does so, and to assess...
10.
Dunlop O, Bjorklund R, Bruun J, Evensen R, Goplen A, Liestol K, et al.
Acta Neurol Scand
. 2002 May;
105(4):270-5.
PMID: 12004769
OBJECTIVES- To ask if slowed motor speed predicts later human immunodeficiency virus (HIV) dementia and HIV encephalitis. METHODS- In 100 deceased acquired immunodeficiency syndrome (AIDS) patients prior results from repeated...